iRhythm Technologies, Inc. (IRTC) Stock

iRhythm Technologies, Inc. is a pioneering digital healthcare company specializing in ambulatory electrocardiogram (ECG) monitoring solutions tailored for patients at risk of arrhythmias across the United States. Central to its offerings is the Zio service, a state-of-the-art ambulatory cardiac monitoring solution. This innovative system integrates a wire-free, patch-based wearable biosensor with a cloud-based data analytics platform, empowering physicians with continuous monitoring capabilities to facilitate timely diagnosis and management of arrhythmias.

The company's flagship products, Zio XT and AT monitors, feature single-use, wire-free, wearable patch-based biosensors that meticulously record patients' heartbeats and ECG data. These devices provide comprehensive insights into cardiac activity, supporting healthcare providers in delivering personalized care and optimizing treatment outcomes.

iRhythm Technologies collaborates closely with Verily Life Sciences LLC under a development agreement aimed at advancing next-generation atrial fibrillation screening, detection, and monitoring products. This strategic partnership underscores iRhythm's commitment to innovation and enhancing its technological capabilities to address evolving healthcare needs.

Founded in 2006 and headquartered in San Francisco, California, iRhythm Technologies continues to lead the charge in digital healthcare innovation. With a steadfast focus on leveraging cutting-edge technology to improve patient care, the company remains dedicated to advancing the field of cardiac monitoring and enhancing clinical decision-making processes for healthcare professionals worldwide.